SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0000902664-23-002445
Filing Date
2023-04-03
Accepted
2023-04-03 13:46:14
Documents
1

Document Format Files

Seq Description Document Type Size
1 Y-MABS THERAPEUTICS, INC. p23-1221sc13g.htm SC 13G 109323
  Complete submission text file 0000902664-23-002445.txt   110825
Mailing Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169
Business Address 230 PARK AVENUE SUITE 3350 NEW YORK NY 10169 212-847-9841
Y-mAbs Therapeutics, Inc. (Subject) CIK: 0001722964 (see all company filings)

IRS No.: 474619612 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90649 | Film No.: 23791785
SIC: 2834 Pharmaceutical Preparations

Mailing Address 295 MADISON AVENUE 32ND FL NEW YORK NY 10017
Business Address 295 MADISON AVENUE 32ND FL NEW YORK NY 10017 917-940-2732
ACORN BIOVENTURES, L.P. (Filed by) CIK: 0001766853 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G